The New Crown vaccine does not cause cancer.
NeoCrown vaccine is not associated with cancer, and there is no clinical data to suggest that NeoCrown vaccine poses a cancer risk when administered. The vaccine is not carcinogenic, and the levels of aluminum hydroxide adjuvant, disodium hydrogen phosphate, sodium chloride, sodium dihydrogen phosphate and histidine contained in the vaccine are relatively low, so the vaccine is not carcinogenic.
After excluding contraindications to the new crown vaccine, such as people who are allergic to the active ingredients of the vaccine, any of the inactive ingredients, and substances used in the production process, people with indications for the vaccine can mobilize their own body’s immune function to produce antibodies against the new coronavirus, thus avoiding viral infections and lowering the prevalence of new crown pneumonia.
Adverse reactions such as pain and tenderness at the injection site, as well as fever may occur after injection of the new coronavirus vaccine.
Therefore, it is recommended that people who are eligible for the vaccination should receive the vaccine under the supervision of a doctor.
Note: The terms “new coronavirus pneumonia” and “new coronavirus pneumonia” mentioned in this article were renamed to “new coronavirus infection” on December 26, 2022, as announced by the National Health Commission.